National Cancer Institute; Notice of Closed Meetings, 22839 [2017-10021]
Download as PDF
<![CDATA[
22839
Federal Register / Vol. 82, No. 95 / Thursday, May 18, 2017 / Notices
for a larger sample size from which to
generalize conclusions, and reduce the
overall burden of response on RWHAP
providers and clients. The objectives of
both studies will be achieved through
collection of the following data:
• RWHAP provider interviews—Site
staff interviewees (in person);
• RWHAP client surveys—Clients
with detectable and undetectable viral
load at each clinic;
• RWHAP client records
abstraction—Medical chart and
administrative records (e.g., service
utilization and health outcomes data);
• RWHAP site survey data—Site
Director responses; and
RWHAP client semi-structured
interviews—Clients with detectable and
undetectable viral load.
These studies will build upon and
complement HAB’s study focusing on
RWHAP outcomes within the context of
the changing health care landscape; and
will use the RWHAP site survey and
chart abstraction instruments that were
submitted as part of that study. The data
will be collected by a contractor
selected by HRSA.
Likely Respondents: RWHAP
Administrators, RWHAP Care Providers,
and RWHAP Clients.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating, and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below. Both
research studies are included in the
table, with burden proportional to the
number of RWHAP provider sites from
which each study will collect data: 25
distinct facilities for Assessing Client
Factors Associated with Detectable HIV
Viral Loads and 50 distinct facilities for
Models of Care and the Ryan White
HIV/AIDS Program. The table below
provides the level of burden inclusive of
both studies.
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
Number of
respondents
Form name
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total
responses
Total burden
hours
Site Survey * .........................................................................
Medical Records Sample Selection Guide* .........................
Provider Interview Guide .....................................................
Focus Groups Guide ............................................................
Client Survey ........................................................................
Client semi-structured interview ...........................................
75
75
375
400
500
150
1
1
1
1
1
1
75
75
375
400
500
150
0.5
1
2
1.5
1
1
37.5
75
750
600
500
150
Total ..............................................................................
1,575
........................
1,575
........................
2112.5
* The site survey and medical records sample selection instruments were submitted in March 2017 for OMB review as part of the Ryan White
HIV/AIDS Program Outcomes and Expanded Insurance Coverage Information Collection Request.
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Jason E. Bennett,
Director, Division of the Executive Secretariat.
[FR Doc. 2017–10060 Filed 5–17–17; 8:45 am]
BILLING CODE 4165–15–P
jstallworth on DSK7TPTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
VerDate Sep<11>2014
13:43 May 17, 2017
Jkt 241001
hereby given of meetings of the Board of
Scientific Counselors for Basic Sciences,
National Cancer Institute.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Cancer Institute, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors for Basic Sciences, National
Cancer Institute.
Date: July 10, 2017.
Time: 9:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health, 31
Center Drive, Building 31, C-Wing, 6th Floor,
Conference Room 6, Bethesda, MD 20892.
Contact Person: Mehrdad Tondravi, Ph.D.,
Chief, Institute Review Office, Office of the
PO 00000
Frm 00038
Fmt 4703
Sfmt 9990
Director, National Cancer Institute, National
Institutes of Health, 9609 Medical Center
Drive, Room 3W–302, Bethesda, MD 20892,
240–276–5664, tondravim@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: May 12, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–10021 Filed 5–17–17; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\18MYN1.SGM
18MYN1
]]>Agencies
[Federal Register Volume 82, Number 95 (Thursday, May 18, 2017)]
[Notices]
[Page 22839]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-10021]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of meetings of the
Board of Scientific Counselors for Basic Sciences, National Cancer
Institute.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), Title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the National
Cancer Institute, including consideration of personnel qualifications
and performance, and the competence of individual investigators, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Board of Scientific Counselors for Basic
Sciences, National Cancer Institute.
Date: July 10, 2017.
Time: 9:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health, 31 Center Drive, Building
31, C-Wing, 6th Floor, Conference Room 6, Bethesda, MD 20892.
Contact Person: Mehrdad Tondravi, Ph.D., Chief, Institute Review
Office, Office of the Director, National Cancer Institute, National
Institutes of Health, 9609 Medical Center Drive, Room 3W-302,
Bethesda, MD 20892, 240-276-5664, tondravim@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: May 12, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-10021 Filed 5-17-17; 8:45 am]
BILLING CODE 4140-01-P
